AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 59 filers reported holding AMPIO PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -80.0% | 29,526 | -6.3% | 0.00% | – |
| Q2 2022 | $5,000 | -64.3% | 31,526 | 0.0% | 0.00% | – |
| Q1 2022 | $14,000 | -26.3% | 31,526 | -6.2% | 0.00% | – |
| Q4 2021 | $19,000 | -67.8% | 33,626 | -5.6% | 0.00% | – |
| Q3 2021 | $59,000 | 0.0% | 35,626 | 0.0% | 0.00% | – |
| Q2 2021 | $59,000 | 0.0% | 35,626 | +1.7% | 0.00% | – |
| Q1 2021 | $59,000 | +7.3% | 35,044 | 0.0% | 0.00% | – |
| Q4 2020 | $55,000 | +77.4% | 35,044 | +6.1% | 0.00% | – |
| Q3 2020 | $31,000 | +138.5% | 33,044 | +57.4% | 0.00% | – |
| Q2 2020 | $13,000 | +62.5% | 20,996 | 0.0% | 0.00% | – |
| Q1 2020 | $8,000 | +14.3% | 20,996 | +69.3% | 0.00% | – |
| Q4 2019 | $7,000 | 0.0% | 12,400 | -21.2% | 0.00% | – |
| Q3 2019 | $7,000 | +16.7% | 15,734 | 0.0% | 0.00% | – |
| Q2 2019 | $6,000 | +20.0% | 15,734 | +52.3% | 0.00% | – |
| Q1 2019 | $5,000 | -96.6% | 10,334 | -71.7% | 0.00% | -100.0% |
| Q4 2017 | $149,000 | – | 36,546 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,595,484 | $5,710,000 | 4.85% |
| Cypress Capital Management LLC (WY) | 321,725 | $708,000 | 0.74% |
| Noven Financial Group, Inc. | 103,964 | $229,000 | 0.12% |
| Transform Wealth, LLC | 205,481 | $452,000 | 0.08% |
| Cutter & CO Brokerage, Inc. | 50,000 | $110,000 | 0.04% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 44,500 | $98,000 | 0.04% |
| GHP Investment Advisors, Inc. | 100,000 | $220,000 | 0.03% |
| BRIGHTON JONES LLC | 85,555 | $188,000 | 0.02% |
| Valeo Financial Advisors, LLC | 330,000 | $155,000 | 0.02% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 27,348 | $60,000 | 0.02% |